Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The acute brain response to levodopa heralds dyskinesias in Parkinson disease.

Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Løkkegaard A, Siebner HR.

Ann Neurol. 2014 Jun;75(6):829-36. doi: 10.1002/ana.24138. Epub 2014 May 28.

2.

Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.

Herz DM, Haagensen BN, Nielsen SH, Madsen KH, Løkkegaard A, Siebner HR.

Mov Disord. 2016 Apr;31(4):521-9. doi: 10.1002/mds.26540. Epub 2016 Mar 8.

3.

Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans.

Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Løkkegaard A, Siebner HR.

Brain. 2015 Jun;138(Pt 6):1658-66. doi: 10.1093/brain/awv096. Epub 2015 Apr 15.

4.

The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias.

Cerasa A, Donzuso G, Morelli M, Mangone G, Salsone M, Passamonti L, Augimeri A, Arabia G, Quattrone A.

Mov Disord. 2015 Dec;30(14):1912-20. doi: 10.1002/mds.26378. Epub 2015 Aug 14.

PMID:
26275050
5.

Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.

Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Mov Disord. 2012 Mar;27(3):364-71. doi: 10.1002/mds.24017. Epub 2011 Nov 10.

PMID:
22076870
6.

Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.

Cerasa A, Salsone M, Morelli M, Pugliese P, Arabia G, Gioia CM, Novellino F, Quattrone A.

Parkinsonism Relat Disord. 2013 Oct;19(10):883-8. doi: 10.1016/j.parkreldis.2013.05.015. Epub 2013 Jun 14.

PMID:
23769805
7.

Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.

Cerasa A, Messina D, Pugliese P, Morelli M, Lanza P, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Mov Disord. 2011 Apr;26(5):807-12. doi: 10.1002/mds.23660. Epub 2011 Mar 7.

PMID:
21384430
8.

A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.

Cerasa A, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, Stampanoni Bassi M, Ponzo V, Picazio S, Passamonti L, Salsone M, Augimeri A, Caltagirone C, Quattrone A.

Brain. 2015 Feb;138(Pt 2):414-27. doi: 10.1093/brain/awu329. Epub 2014 Nov 19.

PMID:
25414038
9.

Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.

Chelaru MI, Duval C, Jog M.

J Neurosci Methods. 2010 Jan 30;186(1):81-9. doi: 10.1016/j.jneumeth.2009.10.015. Epub 2009 Oct 28.

PMID:
19878692
10.
11.

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.

Oliveri RL, Annesi G, Zappia M, Civitelli D, Montesanti R, Branca D, Nicoletti G, Spadafora P, Pasqua AA, Cittadella R, Andreoli V, Gambardella A, Aguglia U, Quattrone A.

Neurology. 1999 Oct 22;53(7):1425-30.

PMID:
10534246
12.

Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.

Ahmed I, Bose SK, Pavese N, Ramlackhansingh A, Turkheimer F, Hotton G, Hammers A, Brooks DJ.

Brain. 2011 Apr;134(Pt 4):979-86. doi: 10.1093/brain/awr028. Epub 2011 Mar 2.

PMID:
21371994
13.

Abnormal bidirectional plasticity-like effects in Parkinson's disease.

Huang YZ, Rothwell JC, Lu CS, Chuang WL, Chen RS.

Brain. 2011 Aug;134(Pt 8):2312-20. doi: 10.1093/brain/awr158. Epub 2011 Jul 8.

PMID:
21742734
14.

Immediate and sustained relief of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimulation lead. Case report.

Alterman RL, Shils JL, Gudesblatt M, Tagliati M.

Neurosurg Focus. 2004 Jul 15;17(1):E6.

PMID:
15264775
15.

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.

de la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ.

Brain. 2004 Dec;127(Pt 12):2747-54. Epub 2004 Aug 25.

PMID:
15329355
16.

Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.

Van Gerpen JA, Kumar N, Bower JH, Weigand S, Ahlskog JE.

Arch Neurol. 2006 Feb;63(2):205-9.

PMID:
16476808
17.

Molecular imaging of levodopa-induced dyskinesias.

Niccolini F, Rocchi L, Politis M.

Cell Mol Life Sci. 2015 Jun;72(11):2107-17. doi: 10.1007/s00018-015-1854-x. Epub 2015 Feb 15. Review.

PMID:
25681866
18.

Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.

Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O'Sullivan SS, Revesz T, Finkelstein DI, Storey E, Williams DR.

Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4.

PMID:
25649148
19.

Early morning off-medication dyskinesias, dystonia, and choreic subtypes.

Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG.

Arch Neurol. 2001 Sep;58(9):1379-82.

PMID:
11559308
20.

Supplemental Content

Support Center